VALEANT PHARMACEUTICALS INTL INC T.VRX

Valeant Pharmaceuticals Announces Expanded Discounts

[Defaulter]

Valeant Pharmaceuticals Announces Expanded Discounts For Nitropress And Isuprel 15 minutes ago - ACQUIREMEDIA LAVAL, Quebec, May 16, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) ("Valeant" or the "Company") today announced that, pursuant to a recommendation by its Patient Access and Pricing Committee, the company will make available to all hospitals in the United States an enhanced rebate program to reduce the price of Nitropress and Isuprel. Under the enhanced program, all hospitals are eligible for a rebate of at least 10%, with rebates totaling 20%, 30% or 40% based on volume purchased during a calendar quarter for hospitals that purchase large volumes of the relevant drug. Hospitals will receive these discounts primarily through their group purchasing organization (GPO). Hospitals that don't buy drugs through a GPO can access the program by contacting Valeant customer service. The rebate program is effective immediately, with hospitals receiving rebates after the end of the quarter in which the purchases were made. The Patient Access and Pricing Committee also confirmed that there would be no further price increases for these products or reductions to the discount levels in the rebate program. "Under this new program, the discounts we previously implemented for Nitropress and Isuprel will be simplified and more accessible," said Joseph Papa, Chairman and Chief Executive Officer of Valeant. "I understand the concerns our partners in the health care community have had about the pricing of these drugs, and we want to ensure hospitals and patients can get the drugs they need. "I also want to thank the Senate Committee on Aging and the House Committee on Oversight and Government Reform for the attention they have brought to this issue, and specifically to gaps they identified in the previous program," Papa continued. "We are committed to getting this right." More information regarding this program can be found on Valeant's website at https://www.valeant.com/about/us-assistance-programs.

[Joe454]

This post has been removed in accordance with Community Policy

[DrStockHouse]

Looks like you are an idiot....!!!

[Joe454]

This post has been removed in accordance with Community Policy

[Lostinmarket123]

Well said joe...my experience says Those who do not respect others views are usually never making money ... Stock going down on good news is considered terrible in stock market .. It tells you what future the stock holds in coming months

[DrStockHouse]

You scared me lost.... I sold my position!!! Is that what you want? What a bench of cockroach....its a good time to buy if you want to make money in coming months idiots...

[Lostinmarket123]

Now we get it .. So you get scared and star behaving like an uncivilized kid if someone expresses different opinion... You need to see a doctor ... Stock house kid

[Joe454]

This post has been removed in accordance with Community Policy

[Defaulter]

You're right. It is financially overextended in its present state. However, it will not be in its 'present state' for very long. While it may never return to $340, it will however, return to a much higher sp than it sits currently.

[Joe454]

This post has been removed in accordance with Community Policy

[Lostinmarket123]

What's happening to Vrx is called band shift ... If Vrx survives it will establish a new trading range ... It may or may not go to 10 -20. May be 30-50 is the new trading range ... My prediction is we will see that in next year or so ... How long will it trade  ....no one can predict... Will it go up ...80-90 may be possible just like 10-20 is possible...its will remain a good trading

[Defaulter]

There are investors on both sides of the trade not respecting other investor's views....so is everyone not making any money??